Russian government approves new plan for pharma import substitution

The Russian government plans to approve a new plan of import substitution in the national pharmaceutical industry shortly, according to Sergey Tsyb, Russia’s Deputy Minister of Industry and Trade, reports The Pharma Letter’s local correspondent.

The new plan will involve the achievement of one of the most ambitious state goals in the Russian pharmaceutical industry, and in particular the increase of the share of domestic drugs up to 90% by 2018.

The plan also involves the provision of four new industry subsidies, two of which will be provided to domestic drugmakers, while two others for the domestic producers of medical devices, as well as consumables.